Accueil   Diary - News   All news GTP Bioways expands analytical expertise in the development and safety of biotherapeutics with the acquisition of IDBiotech

GTP Bioways expands analytical expertise in the development and safety of biotherapeutics with the acquisition of IDBiotech

 

GTP Bioways, which specialises in the production of biotherapies and nanotherapies, announces today it has acquired IDBiotech. Based in Issoire (France), CRO IDBiotech specialises in the development and manufacturing of immunoassays and the provision of analytical services for the quantification of target biomolecules or HCP-type contaminants.

 

This acquisition allows GTP Bioways to expand its analytical service provision and optimise its support to biopharmaceutical companies developing innovative therapies, through the offer of custom immunoassay development adapted to their needs.

 

Read the press release